FFA
KURA icon

Farther Finance Advisors’s Kura Oncology KURA Stock Holding History

Farther Finance Advisors’s Portfolio KURA Stock Details KURA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$17.1K Buy
1,597
+479
+43% +$5.36K ﹤0.01% 4260
2026
Q2 		$12.3K Buy
1,118
+476
+74% +$4.49K ﹤0.01% 4296
2026
Q1 		$5.35K Sell
642
-863
-57% -$7.41K ﹤0.01% 4459
2025
Q4 		$15.6K Buy
1,505
+1,320
+714% +$13.8K ﹤0.01% 3601
2025
Q3 		$1.64K Buy
185
+152
+461% +$1.08K ﹤0.01% 4210
2025
Q2 		$190 Sell
33
-71
-68% -$435 ﹤0.01% 4217
2025
Q1 		$664 Buy
104
+89
+593% +$694 ﹤0.01% 3724
2024
Q4 		$131 Sell
15
-12
-44% -$173 ﹤0.01% 3743
2024
Q3 		$528 Buy
27
+12
+80% +$243 ﹤0.01% 3414
2024
Q2 		$318 Hold
15
– – ﹤0.01% 3386
2024
Q1 		$327 Hold
15
– – ﹤0.01% 3145
2023
Q4 		$216 Buy
+15
New +$147 ﹤0.01% 3213

Other funds holding KURA

GI
GAMMA Investing Foster City, California $2.96B AUM 34.38% 1-Year Est. Return
VCM
Versant Capital Management Phoenix, Arizona $1.17B AUM 28.44% 1-Year Est. Return
MPWT
MassMutual Private Wealth & Trust Windsor, Connecticut $3.79B AUM 19.33% 1-Year Est. Return
CA
CoreCap Advisors Southfield, Michigan $3.48B AUM 21.43% 1-Year Est. Return

Farther Finance Advisors's KURA Position: Q3 2026 in Review

Farther Finance Advisors increased its Kura Oncology (KURA) stake by 43% in Q3 2026, buying an estimated $5.36K and bringing the position to 1,597 shares worth $17.1K. The position accounts for ﹤0.01% of the portfolio, ranked #4260.

Farther Finance Advisors first reported a position in KURA in Q4 2023 and has held it in 12 quarters since. 5 funds tracked by Wall St. Rank hold KURA as of Q3 2026.

  • Farther Finance Advisors held 1,597 shares of Kura Oncology worth $17.1K as of Q3 2026.
  • Farther Finance Advisors bought 479 Kura Oncology shares in Q3 2026, an estimated $5.36K.
  • Kura Oncology made up ﹤0.01% of Farther Finance Advisors's portfolio in Q3 2026, its #4260 holding.
  • Farther Finance Advisors first reported a position in Kura Oncology in Q4 2023 and has held it in 12 quarters since.
  • 5 funds tracked by Wall St. Rank held Kura Oncology as of Q3 2026.

Based on Farther Finance Advisors's 13F filing for Q3 2026, filed 8 Oct 2026.